Point of Care (POC) Haematology Diagnostics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Dec 2023 Pages: 164 SKU: IRTNTR45645

Point of Care (POC) Haematology Diagnostics Market 2024-2028

The global point of care (POC) haematology diagnostics market size is estimated to grow by USD 7.15 billion at a CAGR of 10.33% between 2023 and 2028. 

The global point of care hematology diagnostics market is witnessing an increase in the number of product launches, which is driving the adoption of these new and advanced solutions across diagnostic laboratories globally. Additionally, the launch of new and advanced products is enabling vendors to gain a competitive edge over their rivals by bringing significant product differentiation. For example, in March 2022, Mindray launched the new BC-700 Series, a breakthrough hematology analyzer series that includes both CBC and erythrocyte sedimentation rate (ESR) tests. In addition, the acceptance of technologically advanced POC hemoglobin analyzers has also increased owing to their increased availability and faster results. Consequently, with the increasing number of new product launches, the global POC hematology diagnostics market is expected to grow during the forecast period.

Technavio has segmented the market into End-user, Product, and Geography

  • The end-user segment includes hospitals and clinics, homecare settings, and clinical diagnostic laboratories
  • The product segment includes consumables and systems
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our Point of Care Haematology Diagnostics Market examines historic data from 2018 - 2022 , besides analyzing the current market scenario.

What will be the size of the POC Haematology Diagnostics Market During the Forecast Period?

To learn more about this report, Download Report Sample

POC Haematology Diagnostics Market Segmentation by End-user, Product, and Geography Analysis

End-user Analysis 

Hospitals and Clinics

The market share growth by the hospitals and clinics segment will be significant during the forecast period. The hospitals and clinics segment is the key segment that represents different point of care hematology diagnostics market dynamics and contributes to the overall development of POC hematology diagnostics. Hospitals are one of the leading end-users in the global POC hematology diagnostics market. They offer a wide range of healthcare services, have a well-developed infrastructure, and have a high patient volume. As a result, they often need efficient and fast diagnostic solutions to improve patient care, treatment decisions, and overall healthcare outcomes.

Get a glance at the market contribution of various segments Download PDF Sample

The hospitals and clinics segment was valued at USD 3.55 billion in 2018. Clinics are another important segment of the global point of care (POC) haematology diagnostics market, encompassing both primary care clinics and specialty clinics. POC hematological diagnostics in clinics play an important role in facilitating rapid diagnosis during initial consultations, allowing for immediate interventions and tailored treatment plans. Thus, such factors will drive the growth of the hospitals and clinics segment and will fuel the growth of the global POC hematology diagnostics market during the forecast period.

Product Analysis

Consumables

Consumables contain tubes, accessories, reagents, controls, and kits that are usually used during several hematological diagnostic tests and assays. The consumables are slightly expensive than systems; yet, the use of the consumables is very high depending upon the number of times a test is performed. Moreover, vendors are constantly boosting their investments in product R&D to develop highly precise and accurate reagents and kits for bringing consistency in test results during repetitive testing. Furthermore, due to the increasing burden on laboratories, the demand for rapid tests that can be performed at patients' sites is increasing, which is expected to promote the revenue growth of the consumables segment and fuel the point of care hematology diagnostics market during the forecast period.

Systems

The systems include POC hematology analyzers, readers, and centrifuge. POC systems are purchased once based on requirements and usage. Growing advances in POC hematology diagnostic systems offering varied features and enhancements are key factors driving the adoption of new POC hematology diagnostics. To increase the market share, various market players are focusing on increasing the number of product launches. In addition, market players oversee and efficiently analyze such requirements from end-users to target specific features necessary for product advancement. Some of such innovations and feature enhancements include miniaturization, integration of AI, and simultaneous processing capabilities. Thus, the new product launch and technological advances will drive the growth of the market during the forecast period. 

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America was the largest market for POC hematology diagnostics in 2023 due to the increasing prevalence of hematology conditions, such as thalassemia, sickle cell disease, and polycythemia. Furthermore, the market has the presence of several market players, such as Abbott Laboratories (Abbott), Drucker Diagnostics LLC, SD. Sight Diagnostics Ltd., Danaher Corp.(Danaher), and Nova Biomedical Corp.

Moreover, the above-mentioned point of care (POC) haematology diagnostics market players have a strong supply chain in the region, which is helping them to enable the easy availability of their advanced products. In addition, in the US, the rapid adoption of next-generation POC hematology diagnostic devices and handheld devices in physicians' offices is boosting the demand for POC hematology diagnostics, as these analyzers are compact and do not require much floor space. Players such as Abbott and Danaher have a strong presence in the US. Hence, such factors are expected to drive POC haematology diagnostics market growth in this region during the forecast period. 

Buy Full Report Now

Key POC Haematology Diagnostics Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

A. Menarini Industrie Farmaceutiche Riunite Srl: The company offers POC hematology diagnostics systems such as Medonic-M of different models which are suitable for use in different situations such as Decentralized stations on the territory, Analysis laboratories, Medical studies, Pre-donation screening and Emergency rooms.

  • Abbott Laboratories
  • Chengdu Seamaty Technology Co. Ltd.
  • Danaher Corp.
  • DIAGON Kft.
  • Diamond Diagnostics Inc.
  • Drucker Diagnostics LLC
  • EKF Diagnostics Holdings Plc
  • F. Hoffmann La Roche Ltd.
  • HORIBA Ltd.
  • Medsource Ozone Biomedicals Pvt. Ltd.
  • Norma Instruments Zrt.
  • Nova Biomedical Corp.
  • PixCell Medical Technologies Ltd.
  • S.D. Sight Diagnostics Ltd.,
  • Sekisui Diagnostics LLC
  • Mindray Bio medical Electronics Co. Ltd.
  • Siemens AG
  • Sysmex Corp.
  • Transasia Bio Medicals Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

POC Haematology Diagnostics Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key POC Haematology Diagnostics Market Drivers

Paradigm shift from benchtop to portable hematology diagnostic systems is the key factor driving market growth. The growing diversity of tests that can be undertaken near the bedside of patients denotes the prevalence of multi-parameter checking POC devices. The accuracy of portable POC hematology diagnostic systems and several benefits associated with their use across routine procedures have motivated end-users such as clinical diagnostic laboratories, hospital-based laboratories, and independent laboratories to switch over to the POC variant from the benchtop variant. Cost-effectiveness and rapid turnaround times are also encouraging adoption.

Furthermore, clinical laboratories that adopt POC hematology diagnostic solutions are equipped with PC interfaces and advanced technologies to provide accurate test outcomes. These analyzers include other advantages such as extended test menus, quality control features, adjustment programs, and advanced interfaces, such as touchscreen-enhanced symbols, which are encouraging the adoption of POC hematology diagnostic solutions globally. Thus, such factors are expected to fuel the growth of the market during the forecast period.

Significant POC Haematology Diagnostics Market Trends

An increase in the number of OEMs is the primary trend shaping market growth. The cost of raw materials used to produce POC hematology diagnostic analyzers is very high, and it further requires additional costs such as land, labor, and R&D, which need substantial financial resources. Hence, instead of establishing new manufacturing plants, market players directly purchase the devices from the OEMs, which saves their costs regarding land, labor, and R&D.

For example, Boule is an OEM that supplies reagents directly to the customer with the inclusion of the customer brand before it reaches the end-user. Also, Labcon, an OEM, offers customized reagents for use in the analyzers. These measures will lead to an increase in the growth of the global POC hematology diagnostics market during the forecast period.

Major POC Haematology Diagnostics Market Challenges

The high cost of hematology diagnostic products is a challenge that affects market growth. The majority of the POC hematology diagnostic products manufactured by various global and local market players are cost-efficient. However, the cost associated with hematology conditions such as management of thalassemia and anemia is high, which leads to out-of-pocket expenditure. The high cost of next-generation hematology analyzers can become a challenge for small and medium-sized laboratories.

Furthermore, the constant purchase of consumables, such as reagents, cartridges, and test tubes, increases the cost burden. For example, the average cost of a hematology analyzer ranges between USD 35,000 and 65,000. In addition, the cost of reagents, which are being used in the analyzer to conduct the test, increases the cost burden further. The average price range of the consumables is around USD 45 - USD 70. Hence, the high cost of hematology diagnostic products impedes the market growth during the forecast period.

Buy Now Full Report

Key POC Haematology Diagnostics Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global POC Haematology Diagnostics Market Customer Landscape

Segment Overview

The POC haematology diagnostics market report forecasts market growth by revenue at global, regional & country levels and analyzes the latest trends and growth opportunities from 2018 to 2028. 

  • End-user Outlook
    • Hospitals and clinics
    • Homecare settings
    • Clinical diagnostic laboratories
  • Product Outlook
    • Consumables
    • Systems
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Argentina
      • Australia
      • Brazil

POC Haematology Diagnostics Market Scope

Report Coverage

Details

Page number

164

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 10.33%

Market Growth 2024-2028

USD 7.15 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

9.65

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, Chengdu Seamaty Technology Co. Ltd., Danaher Corp., DIAGON Kft., Diamond Diagnostics Inc., Drucker Diagnostics LLC, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., HORIBA Ltd., Medsource Ozone Biomedicals Pvt. Ltd., Norma Instruments Zrt., Nova Biomedical Corp., PixCell Medical Technologies Ltd., S.D. Sight Diagnostics Ltd., Sekisui Diagnostics LLC, Mindray Bio medical Electronics Co. Ltd., Siemens AG, Sysmex Corp., and Transasia Bio Medicals Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this POC Haematology Diagnostics Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the POC haematology diagnostics market between 2024 and 2028
  • Precise estimation of the POC haematology diagnostics market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of POC haematology diagnostics market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global POC hematology diagnostics market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global poc hematology diagnostics market 2018 - 2022 ($ billion)
    • 4.2 End-user Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)
    • 4.3 Product Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Hospitals and clinics - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
    • 6.4 Homecare settings - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Homecare settings - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Homecare settings - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Homecare settings - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Homecare settings - Year-over-year growth 2023-2028 (%)
    • 6.5 Clinical diagnostic laboratories - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 43: Data Table on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 44: Chart on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by End-user
      • Exhibit 46: Market opportunity by End-user ($ billion)
      • Exhibit 47: Data Table on Market opportunity by End-user ($ billion)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 48: Chart on Product - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
    • 7.2 Comparison by Product
      • Exhibit 50: Chart on Comparison by Product
      • Exhibit 51: Data Table on Comparison by Product
    • 7.3 Consumables - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Consumables - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Consumables - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Consumables - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
    • 7.4 Systems - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Systems - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Systems - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Systems - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Systems - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Product
      • Exhibit 60: Market opportunity by Product ($ billion)
      • Exhibit 61: Data Table on Market opportunity by Product ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Germany - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.9 UK - Market size and forecast 2023-2028
      • Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.10 China - Market size and forecast 2023-2028
      • Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.11 Canada - Market size and forecast 2023-2028
      • Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ billion)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 A. Menarini Industrie Farmaceutiche Riunite Srl
              • Exhibit 111: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
              • Exhibit 112: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
              • Exhibit 113: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
            • 12.4 Abbott Laboratories
              • Exhibit 114: Abbott Laboratories - Overview
              • Exhibit 115: Abbott Laboratories - Business segments
              • Exhibit 116: Abbott Laboratories - Key news
              • Exhibit 117: Abbott Laboratories - Key offerings
              • Exhibit 118: Abbott Laboratories - Segment focus
            • 12.5 Danaher Corp.
              • Exhibit 119: Danaher Corp. - Overview
              • Exhibit 120: Danaher Corp. - Business segments
              • Exhibit 121: Danaher Corp. - Key news
              • Exhibit 122: Danaher Corp. - Key offerings
              • Exhibit 123: Danaher Corp. - Segment focus
            • 12.6 DIAGON Kft.
              • Exhibit 124: DIAGON Kft. - Overview
              • Exhibit 125: DIAGON Kft. - Product / Service
              • Exhibit 126: DIAGON Kft. - Key offerings
            • 12.7 Diamond Diagnostics Inc.
              • Exhibit 127: Diamond Diagnostics Inc. - Overview
              • Exhibit 128: Diamond Diagnostics Inc. - Product / Service
              • Exhibit 129: Diamond Diagnostics Inc. - Key offerings
            • 12.8 Drucker Diagnostics LLC
              • Exhibit 130: Drucker Diagnostics LLC - Overview
              • Exhibit 131: Drucker Diagnostics LLC - Product / Service
              • Exhibit 132: Drucker Diagnostics LLC - Key offerings
            • 12.9 EKF Diagnostics Holdings Plc
              • Exhibit 133: EKF Diagnostics Holdings Plc - Overview
              • Exhibit 134: EKF Diagnostics Holdings Plc - Business segments
              • Exhibit 135: EKF Diagnostics Holdings Plc - Key offerings
              • Exhibit 136: EKF Diagnostics Holdings Plc - Segment focus
            • 12.10 F. Hoffmann La Roche Ltd.
              • Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.11 HORIBA Ltd.
              • Exhibit 142: HORIBA Ltd. - Overview
              • Exhibit 143: HORIBA Ltd. - Business segments
              • Exhibit 144: HORIBA Ltd. - Key offerings
              • Exhibit 145: HORIBA Ltd. - Segment focus
            • 12.12 Medsource Ozone Biomedicals Pvt. Ltd.
              • Exhibit 146: Medsource Ozone Biomedicals Pvt. Ltd. - Overview
              • Exhibit 147: Medsource Ozone Biomedicals Pvt. Ltd. - Product / Service
              • Exhibit 148: Medsource Ozone Biomedicals Pvt. Ltd. - Key offerings
            • 12.13 Nova Biomedical Corp.
              • Exhibit 149: Nova Biomedical Corp. - Overview
              • Exhibit 150: Nova Biomedical Corp. - Product / Service
              • Exhibit 151: Nova Biomedical Corp. - Key offerings
            • 12.14 Mindray Bio medical Electronics Co. Ltd.
              • Exhibit 152: Mindray Bio medical Electronics Co. Ltd. - Overview
              • Exhibit 153: Mindray Bio medical Electronics Co. Ltd. - Product / Service
              • Exhibit 154: Mindray Bio medical Electronics Co. Ltd. - Key offerings
            • 12.15 Siemens AG
              • Exhibit 155: Siemens AG - Overview
              • Exhibit 156: Siemens AG - Business segments
              • Exhibit 157: Siemens AG - Key news
              • Exhibit 158: Siemens AG - Key offerings
              • Exhibit 159: Siemens AG - Segment focus
            • 12.16 Sysmex Corp.
              • Exhibit 160: Sysmex Corp. - Overview
              • Exhibit 161: Sysmex Corp. - Business segments
              • Exhibit 162: Sysmex Corp. - Key offerings
              • Exhibit 163: Sysmex Corp. - Segment focus
            • 12.17 Transasia Bio Medicals Ltd.
              • Exhibit 164: Transasia Bio Medicals Ltd. - Overview
              • Exhibit 165: Transasia Bio Medicals Ltd. - Product / Service
              • Exhibit 166: Transasia Bio Medicals Ltd. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 167: Inclusions checklist
                • Exhibit 168: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 169: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 170: Research methodology
                • Exhibit 171: Validation techniques employed for market sizing
                • Exhibit 172: Information sources
              • 13.5 List of abbreviations
                • Exhibit 173: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              poc haematology diagnostics market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis